Late-onset generalized disorder of peroxisomes
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Peroxisomes are single-membrane-bound subcellular organelles found in almost all eukaryotic cells. There are more than 60 identified enzymes in peroxisomes. Functional peroxisomes are necessary for normal development, and deficiencies of peroxisome number, structure, or function produce severe disease. Peroxisomal disorders are usually diagnosed on the basis of clinical features and increased concentration of very-long-chain fatty acids (VLCFAs).
Peroxisomal disorders are classified into three groups based on biochemical and histologic criteria. [1] Group 1 disorders (e.g., Zellweger syndrome are particularly severe, characterized by defective peroxisome assembly and lacking all peroxisomal functions. Group 2 disorders (e.g., X-linked adrenoleukodystrophy [X-ALD]) have deficiencies of single peroxisomal enzymes and are usually less clinically severe than group 1 disorders. In group 3 disorders, multiple peroxisomal enzymes are defective, but peroxisomes are present as in group 2. We present an unusual case of a 32-year-old man having an atypical clinical course, plasma studies suggestive of a group 2 disorder, and the peroxisomal enzyme profile of group 1 or 3 disorders.
Case report.
This patient presented to the University of Michigan Neurology Clinic as a 32-year-old man with profound dementia and medically refractory epilepsy. His parents were first cousins. Of four siblings, one sister died at age 8 years with a neurologic disorder that included seizures from infancy and severe developmental delay. She never walked, talked, or sat unsupported. Our patient sat at 8 months, walked at 14 months, and talked in sentences at 2 years of age. The age at which cognitive delay became apparent is unknown. At 8 years, he developed generalized tonic-clonic seizures that became medically refractory. Also at age 8 years, he underwent developmental assessment for mental retardation. At that time, he ambulated well, played with his brothers, and performed activities of daily living. Severe hearing impairment …
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Hastening the Diagnosis of Amyotrophic Lateral Sclerosis
Dr. Brian Callaghan and Dr. Kellen Quigg
► Watch
Related Articles
- No related articles found.
Alert Me
Recommended articles
-
Articles
Defective peroxisome biogenesis with a neuromuscular disorder resembling Werdnig-Hoffman diseaseM. R. Baumgartner, N. M. Verhoeven, C. Jacobs et al.Neurology, November 01, 1998 -
Articles
Reinvestigation of trihydroxycholestanoic acidemia reveals a peroxisome biogenesis disorderJ. Gootjes, F. Skovby, E. Christensen et al.Neurology, June 07, 2004 -
Articles
MRI as diagnostic tool in early-onset peroxisomal disordersM.S. van der Knaap, E. Wassmer, N.I. Wolf et al.Neurology, March 28, 2012 -
Resident and Fellow Section
Child Neurology: Zellweger syndromePaul R. Lee, Gerald V. Raymond et al.Neurology, May 13, 2013